Complaints with NPPA about drug shortage up 6-fold in 2017-18

The number of complaints that are filed with the National Pharmaceutical Pricing Authority (NPPA) about unavailability or shortage of drugs have seen a six fold increase in 2017-18, as compared to 2016-17. According to the data of pricing regulator, the number of complaints filed regarding shortage of medicines were just 7 in 2016-17.

Drug pricing: A regulatory tug of war

The pharmaceutical industry has suggested to the central government that it should increase its reviewing powers on the decisions taken by National Pharmaceutical Pricing Authority (NPPA). The regulator is learnt to have responded with a contrarian view that the government should “abandon its archaic practice of reviewing NPPA orders” and, instead, establish an independent appellate tribunal.

4 NCR hospitals jacked up prices of branded drugs 12 fold: NPPA

Some hospitals in the National Capital Region (NCR) prescribed branded medicines that were outside the regulator’s purview and inflated their prices several times in order to boost profit, the National Pharmaceutical Pricing Authority said. Four hospitals in the NCR marked up the retail prices of such medicines as much as 12-fold from the rates at which they were purchased, NPPA said in a report.

NPPA analysis: Three private hospitals earn huge margins on drugs

NPPA analysis: Three private hospitals earn huge margins on drugs | The Indian Express National Pharmaceutical Pricing Authority (NPPA) on Tuesday came out with a price analysis of three unnamed private hospitals in the city that showed huge margins on MRPs kept by these hospitals on drugs and consumables, ranging from 2112 per cent to 116 per cent.

Price control not the best way to achieve affordability: NPPA Chairman Bhupendra Singh

While the National Pharmaceutical Pricing Authority (NPPA) revised the ceiling price on coronary stents on Monday, its Chairman Bhupendra Singh stated on Friday that that the price control is not the best option to achieve affordability. “If you ask me, I don’t consider that price control is the best option to achieve affordability.